Literature DB >> 9226307

Why is female sex an independent predictor of shortened overall survival after proton/photon radiation therapy for skull base chordomas?

E C Halperin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9226307     DOI： 10.1016/s0360-3016(97)00041-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  5 in total

Review 1.  Proton therapy for tumors of the skull base.

Authors:  J E Munzenrider; N J Liebsch
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

2.  OUTCOME OF CLIVAL CHORDOMAS AFTER SKULL BASE SURGERIES WITH MEAN FOLLOW-UP OF 10 YEARS.

Authors:  Takamitsu Tamura; Taku Sato; Yugo Kishida; Masahiro Ichikawa; Keiko Oda; Eiji Ito; Tadashi Watanabe; Jun Sakuma; Kiyoshi Saito
Journal:  Fukushima J Med Sci       Date:  2015-09-11

3.  Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma.

Authors:  M Mima; Y Demizu; D Jin; N Hashimoto; M Takagi; K Terashima; O Fujii; Y Niwa; T Akagi; T Daimon; Y Hishikawa; M Abe; M Murakami; R Sasaki; N Fuwa
Journal:  Br J Radiol       Date:  2013-11-28       Impact factor: 3.039

4.  Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.

Authors:  Alberto Iannalfi; Emma D'Ippolito; Giulia Riva; Silvia Molinelli; Sara Gandini; Gisela Viselner; Maria Rosaria Fiore; Barbara Vischioni; Viviana Vitolo; Maria Bonora; Sara Ronchi; Rachele Petrucci; Amelia Barcellini; Alfredo Mirandola; Stefania Russo; Alessandro Vai; Edoardo Mastella; Giuseppe Magro; Davide Maestri; Mario Ciocca; Lorenzo Preda; Francesca Valvo; Roberto Orecchia
Journal:  Neuro Oncol       Date:  2020-09-29       Impact factor: 12.300

5.  Proton beam therapy for bone sarcomas of the skull base and spine: A retrospective nationwide multicenter study in Japan.

Authors:  Yusuke Demizu; Masashi Mizumoto; Tsuyoshi Onoe; Naoki Nakamura; Yasuhiro Kikuchi; Tetsushi Shibata; Tomoaki Okimoto; Hideyuki Sakurai; Tetsuo Akimoto; Kota Ono; Takashi Daimon; Shigeyuki Murayama
Journal:  Cancer Sci       Date:  2017-04-24       Impact factor: 6.716
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.